Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TREPROSTINIL Cause Blood pressure fluctuation? 195 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 195 reports of Blood pressure fluctuation have been filed in association with TREPROSTINIL (TYVASO). This represents 0.2% of all adverse event reports for TREPROSTINIL.

195
Reports of Blood pressure fluctuation with TREPROSTINIL
0.2%
of all TREPROSTINIL reports
11
Deaths
77
Hospitalizations

How Dangerous Is Blood pressure fluctuation From TREPROSTINIL?

Of the 195 reports, 11 (5.6%) resulted in death, 77 (39.5%) required hospitalization, and 4 (2.1%) were considered life-threatening.

Is Blood pressure fluctuation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 195 reports have been filed with the FAERS database.

What Other Side Effects Does TREPROSTINIL Cause?

Dyspnoea (16,348) Headache (14,051) Diarrhoea (11,335) Nausea (10,320) Cough (8,945) Fatigue (7,440) Dizziness (7,405) Infusion site pain (5,169) Vomiting (5,097) Death (4,764)

What Other Drugs Cause Blood pressure fluctuation?

INFLIXIMAB (2,765) RITUXIMAB (2,405) INFLIXIMAB-DYYB (1,931) TOCILIZUMAB (1,015) METHOTREXATE (827) DROXIDOPA (749) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (705) SACUBITRIL\VALSARTAN (555) PREDNISONE (491) AMLODIPINE (453)

Which TREPROSTINIL Alternatives Have Lower Blood pressure fluctuation Risk?

TREPROSTINIL vs TREPROSTINIL DIOLAMINE TREPROSTINIL vs TRETINOIN TREPROSTINIL vs TRIAMCINOLONE TREPROSTINIL vs TRIAMCINOLONE ACETONIDE TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE

Related Pages

TREPROSTINIL Full Profile All Blood pressure fluctuation Reports All Drugs Causing Blood pressure fluctuation TREPROSTINIL Demographics